Introducing ACUVUE® Abiliti™
A powerful approach to managing myopia.
Myopia is a silent epidemic affecting millions of children around the world—and it is growing fast1. It is the greatest eye health threat of the 21st century2. Research shows that myopia is more than just nearsightedness3. It is a chronic, progressive disease associated with a risk of significant complications later in life3-5 that threaten to take away our most treasured sense: Sight.
Our Commitment
Our commitment to fighting this global health threat.We marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.As one of the world’s most trusted healthcare brands, Johnson & Johnson believes that changing the trajectory of this disease is our responsibility. We’re determined to find ways to manage myopia, potentially reducing the risk of sight-threatening complications in later life.We are doing it through our Abiliti™ portfolio.
- Our Commitment
Our commitment to fighting this global health threat.We marvel at the magic of our eyes, yet we are acutely aware there are many who do not fully experience the wonder of this gift.As one of the world’s most trusted healthcare brands, Johnson & Johnson believes that changing the trajectory of this disease is our responsibility. We’re determined to find ways to manage myopia, potentially reducing the risk of sight-threatening complications in later life.We are doing it through our Abiliti™ portfolio.
Our Commitment